Abstract:Nanosafety assessment has experienced an intense era of research during the past decades driven by a vivid interest of regulators, industry, and society. Toxicological assays based on in vitro cellular models have undergone an evolution from experimentation using nanoparticulate systems on singular epithelial cell models to employing advanced complex models more realistically mimicking the respective body barriers for analyzing their capacity to alter the immune state of exposed individuals. During this phase, a number of lessons were learned. We have thus arrived at a state where the next chapters have to be opened, pursuing the following objectives: (1) to elucidate underlying mechanisms, (2) to address effects on vulnerable groups, (3) to test material mixtures, and (4) to use realistic doses on (5) sophisticated models. Moreover, data reproducibility has become a significant demand. In this context, we studied the emerging concept of adverse outcome pathways (AOPs) from the perspective of immune activation and modulation resulting in pro-inflammatory versus tolerogenic responses. When considering the interaction of nanomaterials with biological systems, protein corona formation represents the relevant molecular initiating event (e.g., by potential alterations of nanomaterial-adsorbed proteins). Using this as an example, we illustrate how integrated experimental-computational workflows combining in vitro assays with in silico models aid in data enrichment and upon comprehensive ontology-annotated (meta)data upload to online repositories assure FAIRness (Findability, Accessibility, Interoperability, Reusability). Such digital twinning may, in future, assist in early-stage decision-making during therapeutic development, and hence, promote safe-by-design innovation in nanomedicine. Moreover, it may, in combination with in silico-based exposure-relevant dose-finding, serve for risk monitoring in particularly loaded areas, for example, workplaces, taking into account pre-existing health conditions. This article is categorized under: Toxicology and Regulatory Issues in Nanomedicine > Toxicology of Nanomaterials.

A Network Toxicology Approach for Mechanistic Modelling of Nanomaterial Hazard and Adverse Outcomes

A network toxicology approach for mechanistic modelling of nanomaterial hazard and adverse outcomes

Prediction of the Neurotoxic Potential of Chemicals Based on Modelling of Molecular Initiating Events Upstream of the Adverse Outcome Pathways of (Developmental) Neurotoxicity

Adverse Outcome Pathway Networks II: Network Analytics.

Network toxicology focused investigation on the impacts of inorganic arsenic and cadmium on human and ecosystem health

Immunotoxicity of nanomaterials in health and disease: Current challenges and emerging approaches for identifying immune modifiers in susceptible populations

Applying quantitative structure–activity relationship approaches to nanotoxicology: Current status and future potential

Toxicity profiling of engineered nanomaterials via multivariate dose-response surface modeling

Assessing network-based methods in the context of system toxicology

Current Knowledge on the Use of Computational Toxicology in Hazard Assessment of Metallic Engineered Nanomaterials

Creative Use of Analytical Techniques and High-Throughput Technology to Facilitate Safety Assessment of Engineered Nanomaterials

Toxicogenomic module associations with pathogenesis: a network-based approach to understanding drug toxicity

A toxicity pathway-oriented approach to develop adverse outcome pathway: AHR activation as a case study

Comparative and mechanistic toxicity assessment of structure-dependent toxicity of carbon-based nanomaterials

Modelling and predicting the biological effects of nanomaterials

A comprehensive framework for evaluating the environmental health and safety implications of engineered nanomaterials

Computational Nanotoxicology Models for Environmental Risk Assessment of Engineered Nanomaterials

Advanced in silico characterization of nanomaterials for nanoparticle toxicology

Biomarkers of susceptibility: State of the art and implications for occupational exposure to engineered nanomaterials

Toxico-Metabolomics of Engineered Nanomaterials: Progress and Challenges

Predictive toxicological paradigm and high throughput approach for toxicity screening of engineered nanomaterials